The Office of National Drug Control Policy (ONDCP) will host a webinar entitled 'Medication Assisted Treatment Programs for Justice Involved Populations' on Tuesday, June 14, from 2-3 p.m. EST.

Approximately 150 substance abuse prevention leaders from across Missouri gathered at CADCA Summit: A Comprehensive Approach to Addressing the Pills to Heroin Epidemic this week in St. Louis at the St. Louis College of Pharmacy.

Summit is Cornerstone of DEA’s 360 Strategy

Families affected by the prescription drug abuse and heroin use epidemic and members of congress took to Capitol Hill this morning to support the passage of the Comprehensive Addiction and Recovery Act (CARA).

At the press conference, House Majority Leader Kevin McCarthy (R-Calif.) addressed the families. Other speakers were Rep. Bob Dold (R-Ill.), Rep. Frank Guinta (R-NH), Rep. Tim Ryan (D-Ohio), Sen. Rob Portman (R-Ohio), and Rep. Sheila Jackson Lee (D-Texas).

Leaders Call on Congress to Swiftly Complete Legislation and Provide Essential Funding

The Collaborative for Effective Prescription Opioid Policies (CEPOP) today voiced strong support for bipartisan action this week on multiple bills to address the opioid abuse, misuse, and diversion ravaging communities and families across the nation. 

CADCA’s Chairman and CEO, Gen. Arthur T. Dean, addressed members of a Bi-Partisan Task Force to Combat the Heroin Epidemic this morning on Capitol Hill.

With the House of Representatives passing 10 opioid bills this week and more votes scheduled for later today, CADCA wanted coalitions to read Gen. Dean’s statement from this morning’s bi-partisan task force meeting.

Here is an excerpt:

Thank you to leaders of the Bi-Partisan Task Force to Combat the Heroin Epidemic for inviting me here today to talk about the critical role of prevention in addressing our nation’s opiate crisis.  

CADCA’s mission is to strengthen the capacity of community coalitions to create and maintain safe, healthy and drug-free communities globally.

We train over 12,000 adult and youth leaders each year on a comprehensive, evidence-based coalition model for community change. 

Yesterday, the House Energy & Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug abuse issues affecting communities across the country.

H.R. 3250, The DXM Abuse Prevention Act, authored by Rep. Bill Johnson (R-Ohio) and Rep. Doris Matsui (D-Calif.) is one such piece of legislation. Long supported by CADCA, the bill would restrict the sale of products containing dextromethorphan (DXM) to adults over age 18 nationwide and place restrictions on distribution of bulk DXM.

The Comprehensive Addiction and Recovery Act is slated for mark-up in the House of Representatives’ Judiciary Committee the last week of this month and House leadership announced floor time for opioid bills, including CARA, during the 2nd week of May.

This news makes our goal to reach 200 co-sponsors in the next month even more important. We are at 112 co-sponsors and need your help to reach our goal of 200 co-sponsors by April 30th. The more co-sponsors we have, the greater the likelihood CARA will pass the House.

Today, after a week of deliberation and consideration of amendments, the U.S. Senate passed S. 524, the Comprehensive Addiction and Recovery Act (CARA), by a vote of 94-1. This is an important victory for the prevention field!

This bipartisan legislation provides numerous provisions aimed at tackling the nation's prescription drug abuse and heroin overdose epidemic, including a $5 million enhancement grant program for current and former Drug-Free Communities grantees to address prescription drug, heroin, and meth crises locally.